Jennifer Laird, Ph.D., D.Sc. is VP, Search & Evaluation Pain & Neurodegeneration at Eli Lilly and Company, based at Lilly’s European Headquarters near London, UK. The global Search & Evaluation team complements Lilly’s internal R&D efforts by evaluating, in-licensing or acquiring assets and technologies and by advancing molecules through discovery and development in collaboration with external partners.
Prior to joining Lilly in 2012, Dr. Laird held various leadership roles in Translational Science, Project Management and Pharmacology at AstraZeneca, in academia and Merck. Dr. Laird received doctorates from Bristol University and University of Alicante, Spain.